β-Arrestin2 is increased in liver fibrosis in humans and rodents
Proc Natl Acad Sci U S A
.
2020 Nov 3;117(44):27082-27084.
doi: 10.1073/pnas.2014337117.
Authors
Robert Schierwagen
1
,
Peter Dietrich
2
3
,
Sabine Klein
1
,
Frank Erhard Uschner
1
,
Cristina Ortiz
1
,
Olaf Tyc
1
,
Sandra Torres
1
,
Claus Hellerbrand
2
,
Tilman Sauerbruch
4
,
Jonel Trebicka
5
6
Affiliations
1
Section for Translational Hepatology, Department of Internal Medicine I, Goethe University Frankfurt, Frankfurt 60590, Germany.
2
Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.
3
Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen 91054, Germany.
4
Department of Internal Medicine I, University of Bonn, Bonn 53127, Germany.
5
Section for Translational Hepatology, Department of Internal Medicine I, Goethe University Frankfurt, Frankfurt 60590, Germany;
[email protected]
.
6
European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
PMID:
33144522
PMCID:
PMC7959505
DOI:
10.1073/pnas.2014337117
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Humans
Liver Cirrhosis*
Rodentia*
beta-Arrestin 1
beta-Arrestins
Substances
beta-Arrestin 1
beta-Arrestins